041830 — InBody Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSuper Stock

Market Cap
KR₩385bn
Enterprise Value
KR₩258bn
Revenue
KR₩234bn

Annual balance sheet for InBody Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	71,429	86,546	98,915	103,629	138,664
Net Total Accounts Receivable
Net Total Receivables	17,398	18,153	17,489	25,291	32,525
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	110,110	135,489	148,964	171,374	213,155
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	75,835	81,731	85,909	91,465	96,972
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	203,760	242,665	274,456	305,817	361,062
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	16,253	19,205	17,451	25,823	32,880
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	20,025	27,405	25,690	32,851	43,215
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	183,735	215,260	248,766	272,966	317,847
Total Liabilities & Shareholders' Equity	203,760	242,665	274,456	305,817	361,062
Total Common Shares Outstanding